251 related articles for article (PubMed ID: 11238034)
21. Expression of cycloxygenase-2 in human bladder and renal cell carcinoma.
Hara S; Kondo Y; Matsuzawa I; Hashimoto Y; Kimura G; Akimoto M; Imura N
Adv Exp Med Biol; 2002; 507():123-6. PubMed ID: 12664575
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of cyclooxygenase-2 in high-grade human transitional cell carcinoma of the upper urinary tract.
Oku S; Higashi M; Imazono Y; Sueyoshi K; Enokida H; Kubo H; Yonezawa S; Shirahama T
BJU Int; 2003 Jan; 91(1):109-14. PubMed ID: 12614262
[TBL] [Abstract][Full Text] [Related]
23. Cyclooxygenase-1 and -2 expression in urothelial carcinomas of the urinary bladder in cows.
Borzacchiello G; Ambrosio V; Galati P; Perillo A; Roperto F
Vet Pathol; 2003 Jul; 40(4):455-9. PubMed ID: 12824517
[TBL] [Abstract][Full Text] [Related]
24. Expression of cyclooxygenase-2 in primary superficial bladder cancer tissue may predict risk of its recurrence after complete transurethral resection.
Okajima E; Uemura H; Ohnishi S; Tanaka M; Ohta M; Tani M; Fujimoto K; Ozono S; Okajima E; Hirao Y
Aktuelle Urol; 2003 Jul; 34(4):256-8. PubMed ID: 14566678
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of cyclooxygenase-2 in squamous cell carcinoma of the urinary bladder.
Shirahama T; Sakakura C
Clin Cancer Res; 2001 Mar; 7(3):558-61. PubMed ID: 11297248
[TBL] [Abstract][Full Text] [Related]
26. Cohort study of COX-1 and COX-2 expression in canine rectal and bladder tumours.
Knottenbelt C; Mellor D; Nixon C; Thompson H; Argyle DJ
J Small Anim Pract; 2006 Apr; 47(4):196-200. PubMed ID: 16573762
[TBL] [Abstract][Full Text] [Related]
27. Cyclooxygenase-2 expression in urinary bladder transitional cell carcinoma and its association with clinicopathological characteristics.
Tabriz HM; Olfati G; Ahmadi SA; Yusefnia S
Asian Pac J Cancer Prev; 2013; 14(8):4539-43. PubMed ID: 24083698
[TBL] [Abstract][Full Text] [Related]
28. Transitional cell carcinoma in fishing cats (Prionailurus viverrinus): pathology and expression of cyclooxygenase-1, -2, and p53.
Landolfi JA; Terio KA
Vet Pathol; 2006 Sep; 43(5):674-81. PubMed ID: 16966444
[TBL] [Abstract][Full Text] [Related]
29. Improved cancer specific-survival in patients with carcinoma invading bladder muscle expressing cyclo-oxygenase-2.
Aziz A; Lessard A; Moore K; Hovington H; Latulippe E; Larue H; Fradet Y; Lacombe L
BJU Int; 2011 Aug; 108(4):531-7. PubMed ID: 21166751
[TBL] [Abstract][Full Text] [Related]
30. Potential of molecular targeted therapy of HER-2 and Cox-2 for invasive transitional cell carcinoma of the urinary bladder.
Naruse K; Yamada Y; Nakamura K; Aoki S; Taki T; Zennami K; Katsuda R; Watanabe M; Nishikawa G; Itoh Y; Mitsui K; Hibi H; Honda N
Oncol Rep; 2010 Jun; 23(6):1577-83. PubMed ID: 20428812
[TBL] [Abstract][Full Text] [Related]
31. Increased expression of cyclooxygenase-2 protein in rat urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl) nitrosamine.
Kitayama W; Denda A; Okajima E; Tsujiuchi T; Konishi Y
Carcinogenesis; 1999 Dec; 20(12):2305-10. PubMed ID: 10590224
[TBL] [Abstract][Full Text] [Related]
32. Qualitative and quantitative analysis of angiogenetic factors in transitional cell bladder carcinoma: relationship with clinical course at 10 years follow-up.
Bartoletti R; Cai T; Nesi G; Sardi I; Rizzo M
Oncol Rep; 2005 Jul; 14(1):251-5. PubMed ID: 15944797
[TBL] [Abstract][Full Text] [Related]
33. Cyclooxygenase-2 expression increases with the stage and grade in transitional cell carcinoma of the urinary bladder.
Wadhwa P; Goswami AK; Joshi K; Sharma SK
Int Urol Nephrol; 2005; 37(1):47-53. PubMed ID: 16132759
[TBL] [Abstract][Full Text] [Related]
34. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
Kunze E; Wendt M; Schlott T
Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
[TBL] [Abstract][Full Text] [Related]
35. Cyclo-oxygenase-2 expression in primary cancers of the lung and bladder compared to normal adjacent tissue.
Sweeney CJ; Marshall MS; Barnard DS; Heilman DK; Billings SD; Cheng L; Marshall SJ; Yip-Schneider MT
Cancer Detect Prev; 2002; 26(3):238-44. PubMed ID: 12269772
[TBL] [Abstract][Full Text] [Related]
36. [Expression of cyclooxygenase-2 in bladder transitional cell carcinoma and the significance thereof].
Yu L; Chen XJ; Shi PQ; Ding Q; Sun CH; Liu GB; Shi DM; Huang YG
Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(38):2683-4. PubMed ID: 19080686
[TBL] [Abstract][Full Text] [Related]
37. Pretreatment tumor prostaglandin E2 concentration and cyclooxygenase-2 expression are not associated with the response of canine naturally occurring invasive urinary bladder cancer to cyclooxygenase inhibitor therapy.
Mutsaers AJ; Mohammed SI; DeNicola DB; Snyder PW; Glickman NW; Bennett PF; de Gortari AE; Bonney PL; Knapp DW
Prostaglandins Leukot Essent Fatty Acids; 2005 Mar; 72(3):181-6. PubMed ID: 15664302
[TBL] [Abstract][Full Text] [Related]
38. Expression of cyclooxygenase-2 and EP4 receptor in transitional cell carcinoma of the upper urinary tract.
Miyata Y; Kanda S; Nomata K; Eguchi J; Kanetake H
J Urol; 2005 Jan; 173(1):56-60. PubMed ID: 15592025
[TBL] [Abstract][Full Text] [Related]
39. Immunocytochemistry of collagenase expression in transitional cell carcinoma of the bladder.
Hattori M; Ohno E; Kuramoto H
Acta Cytol; 2000; 44(5):771-7. PubMed ID: 11015978
[TBL] [Abstract][Full Text] [Related]
40. Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus.
Shamma A; Yamamoto H; Doki Y; Okami J; Kondo M; Fujiwara Y; Yano M; Inoue M; Matsuura N; Shiozaki H; Monden M
Clin Cancer Res; 2000 Apr; 6(4):1229-38. PubMed ID: 10778945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
